Top Clinical Trials companies in Australia by Cash and Short-Term Investments
Australia
# |
Name |
Cash and Short-Term Investments |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 1.66 B
|
June 30, 2024 | USD 169.95 | -0.56% |
|
Australia |
|
| 2 |
USD 122.60 M
|
June 30, 2024 | USD 7.27 | 0.71% |
|
Australia |
|
| 3 |
USD 121.27 M
|
June 30, 2024 | USD 2.09 | 0.97% |
|
Australia |
|
| 4 |
USD 83.93 M
|
Dec. 31, 2023 | USD 18.33 | -0.84% |
|
Australia |
|
| 5 |
USD 62.56 M
|
June 30, 2024 | USD 1.90 | -4.74% |
|
Australia |
|
| 6 |
USD 30.64 M
|
June 30, 2024 | USD 1.23 | -0.40% |
|
Australia |
|
| 7 |
USD 30.08 M
|
June 30, 2024 | USD 0.74 | 1.48% |
|
Australia |
|
| 8 |
USD 21.00 M
|
Dec. 31, 2023 | USD 6.16 | 2.82% |
|
Australia |
|
| 9 |
USD 17.90 M
|
June 30, 2024 | USD 2.33 | 0.08% |
|
Australia |
|
| 10 |
USD 7.56 M
|
June 30, 2024 | USD 0.74 | 0.62% |
|
Australia |
Frequently Asked Questions
-
Which Clinical Trials company in Australia has the highest Cash and Short-Term Investments ?
The Clinical Trials company in Australia with the highest Cash and Short-Term Investments is CSL Limited (ASX: CSL.AX) at USD 1.66 B.
-
Which Clinical Trials company in Australia has the lowest Cash and Short-Term Investments ?
The Clinical Trials company in Australia with the lowest Cash and Short-Term Investments is Monash IVF Group Limited (ASX: MVF.AX) at USD 7.56 M.
-
What are the top 10 Clinical Trials companies in Australia by Cash and Short-Term Investments ?
The top 10 Clinical Trials companies in Australia by Cash and Short-Term Investments are CSL Limited, Clinuvel Pharmaceuticals Limited, Immutep Limited, Telix Pharmaceuticals Limited, Mesoblast Limited, PolyNovo Limited, Cogstate Limited, Anteris Technologies Ltd, Australian Clinical Labs Limited and Monash IVF Group Limited.
-
What are the bottom 10 Clinical Trials companies in Australia by Cash and Short-Term Investments ?
The bottom 10 Clinical Trials companies in Australia by Cash and Short-Term Investments are Monash IVF Group Limited, Australian Clinical Labs Limited, Anteris Technologies Ltd, Cogstate Limited, PolyNovo Limited, Mesoblast Limited, Telix Pharmaceuticals Limited, Immutep Limited, Clinuvel Pharmaceuticals Limited and CSL Limited.
